Home/Filings/4/0001213900-22-014572
4//SEC Filing

MARTELL RON 4

Accession 0001213900-22-014572

CIK 0001788028other

Filed

Mar 22, 8:00 PM ET

Accepted

Mar 23, 6:06 PM ET

Size

5.6 KB

Accession

0001213900-22-014572

Insider Transaction Report

Form 4
Period: 2022-03-21
MARTELL RON
DirectorPresident, CEO and Director
Transactions
  • Award

    Stock Option (right to buy)

    2022-03-21+1,704,3281,704,328 total
    Exercise: $3.54Exp: 2032-03-21Common Stock (1,704,328 underlying)
Footnotes (1)
  • [F1]1/4th of the shares subject to the option shall vest on March 15, 2023, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Documents

1 file

Issuer

Jasper Therapeutics, Inc.

CIK 0001788028

Entity typeother

Related Parties

1
  • filerCIK 0001177079

Filing Metadata

Form type
4
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 6:06 PM ET
Size
5.6 KB